Ignite Creation Date:
2024-05-05 @ 9:11 PM
Last Modification Date:
2024-10-26 @ 10:01 AM
Study NCT ID:
NCT00836927
Status:
TERMINATED
Last Update Posted:
2019-02-18
First Post:
2009-02-03
Brief Title:
Extension Trial of Deforolimus Ridaforolimus MK-8669 in Participants With Advanced Cancer MK-8669-038
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-03
First Submit QC Date:
February 3 2009
Study First Post Date:
2009-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-11
Last Update Post Date:
2019-02-18
Last Update Post Date Type:
ACTUAL